An Innovative Care Model Integrating Mobile Health Support to Promote Weight Management in Adults With Overweight or Obesity
Development and Effectiveness of an Innovative Care Model Integrating Mobile Health Support to Promote Weight Management in Adults With Overweight or Obesity: A Stepped-wedge Cluster Randomized Controlled Trial
1 other identifier
interventional
876
1 country
3
Brief Summary
The objective of this clinical trial is to evaluate whether an innovative care model integrating mobile health (mHealth) support improves weight management in adults with overweight or obesity. The primary research questions are: (1) Does the intervention promote weight change at the 6-month follow-up? (2) Does the intervention enhance physical activity and encourage a healthy diet at the 3- and 6-month follow-ups? To address these questions, researchers will compare the intervention group with a control group to measure changes in weight, physical activity, and dietary habits. At baseline, all participants will complete a survey assessing demographics, body weight, height, central obesity, lifestyle, weight loss history, and expectations. The intervention group will receive a weight management program based on Ecological Momentary Assessment (EMA), incorporating risk-stratified health services, with follow- ups at 3 and 6 months. The control group will receive minimal intervention in the form of general health advice, with follow-ups at the same intervals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2025
CompletedFirst Submitted
Initial submission to the registry
April 17, 2025
CompletedFirst Posted
Study publicly available on registry
May 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 30, 2027
June 11, 2025
June 1, 2025
1.8 years
April 17, 2025
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in weight
Defined as the change in weight of participants over a specified period, this measurement compares the weight change between the intervention and control groups. Participants' weights will be recorded in kilograms at baseline and at a 6-month follow-up using a calibrated digital scale.
6-month from baseline
Secondary Outcomes (17)
Change in weight
3- and 12-month from baseline
Proportion of overweight or obesity
3-, 6- and 12-month follow-up from baseline
Proportion of participants with ≥5% weight change
3-, 6- and 12-month follow-up from baseline
Change in body fat
3- and 6-month follow-up from baseline
Change in muscle mass
3- and 6-month follow-up from baseline
- +12 more secondary outcomes
Study Arms (2)
Control group intervention
ACTIVE COMPARATORParticipants in the control group will receive minimal Intervention. They will not be provided with risk-stratified services.
EMA-based weight management intervention
EXPERIMENTALParticipants in the intervention group will join an mobile health (mHealth) weight management program integrating ecological momentary assessment (EMA) via a mobile app, post-EMA counseling, and risk-stratified coaching. This program provides real-time monitoring and personalized feedback to improve diet and physical activity.
Interventions
Participants will complete four 7-day EMA sessions, reporting their diet for 3 days and physical activity for 4 days by completing five brief daily mobile app surveys (under 2 minutes each), using a 5-digit case number for privacy. The app automatically retrieves Fitbit data-such as step count, moderate-to-vigorous physical activity (MVPA), sedentary behavior, and heart rate- and sends timely reminders if surveys are missed. Within one week after the first EMA session, participants will attend a nurse- led counseling session using the 5A Model (Assess, Advise, Agree, Assist, Arrange), providing tailored feedback based on EMA and Fitbit data, and addressing barriers to change. This is followed by risk-based coaching from a dietitian and fitness instructor, with individualized diet and exercise plans. Between sessions, participants receive ongoing support, including instant reminder messaging and weekly motivational messages to encourage healthy behaviors.
Participants will not receive risk-stratified services but will be provided with informational leaflets offering general advice on maintaining a healthy diet, regular exercise, smoking cessation, and alcohol cessation.
Eligibility Criteria
You may qualify if:
- Hong Kong residents aged ≥18 years;
- able to read and communicate in Chinese;
- own a smartphone with internet access;
- have good mobility alone without gait aid;
- body mass index ≥ 23.0;
- and no contraindication for physical activity as evidenced by: If aged \< 70: do not meet any criteria in PAR-Q, or sign declaration of having medical clearance if meet any criteria in PAR-Q; If aged ≥ 70: sign the declaration about conducting physical activity frequently or having medical clearance
You may not qualify if:
- Have a terminal illness (e.g., advanced cancer, dementia, pulmonary, neurological, motor-neuron, and advanced cardiovascular disease) or with a life expectancy of less than 6 months;
- currently receiving treatment for any cancer (active cancer patients) or cancer survivor of any GI cancers (e.g. colorectal cancer, stomach cancer);
- lactating, pregnant or planning for pregnancy in the coming 6 months;
- have current diagnosis of psychiatric disorder;
- have previous diagnosis of eating disorder;
- have diagnoses of gastrointestinal conditions (e.g. Irritable Bowel Syndrome, Ulcerative Colitis, Crohn's Disease, Coeliac Disease);
- currently receiving intensive diet or exercise treatment;
- have clinical obesity (e.g. confirmation of excess body fat plus limitations of day-to-day activities or signs or symptoms of obesity-related organ dysfunction). Examples of obesity-related organ dysfunction include NAFLD with hepatic fibrosis, the cluster of hyperglycaemia, high triglyceride levels, and low HDL cholesterol levels. Examples of limitations of day-to-day activities include significant age-adjusted limitations of mobility and/or other basic ADL (e.g. bathing, dressing, toileting, continence, eating).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Aberdeen Kaifong Welfare Association
Hong Kong, Hong Kong
Haven of Hope Christian Service
Hong Kong, Hong Kong
Hong Kong Sheng Kung Hui Welfare Council
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Siu Chee Chan Professor
he University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 17, 2025
First Posted
May 30, 2025
Study Start
February 10, 2025
Primary Completion (Estimated)
December 16, 2026
Study Completion (Estimated)
April 30, 2027
Last Updated
June 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
The de-identified individual participant data collected during the trial will be shared at 2 years after article publication with no end date.